Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women

    February 2020 in “ Skin appendage disorders
    Ana Rita Rodrigues-Barata, Oscar M. Moreno-Arrones, David Saceda-Corralo, Juan Jimenez-Cauhe, Diego Fernandez-Nieto, Pedro Jaén-Olasolo, Sergio Vano-Galvan
    Image of study
    TLDR Low-dose oral minoxidil effectively treats female hair loss with good safety.
    This study aimed to evaluate the effectiveness and safety of low-dose oral minoxidil (LDOM) in women with female pattern hair loss (FPHL) in clinical daily practice. A total of 148 FPHL women with a mean age of 47.2 years receiving LDOM were included. Doses between 0.25 and 2 mg of minoxidil were used daily (median 1 mg daily), for a mean time of 9 months (range 6–27). The study found that LDOM may be an effective therapy with a good safety profile for women with FPHL, allowing an excellent long-term compliance. The clinical improvement was higher in more advanced stages of alopecia. The main limitation of the study is the concomitant use of other therapies in a subgroup of patients.
    Discuss this study in the Community →

    Cited in this study

    4 / 4 results

    Related

    9 / 9 results